Robigo
Founded 2021 · 19 employees on LinkedIn · 10 known investors
Robigo develops engineered microbial crop protection products for growers, including a biological solution targeting Sudden Death Syndrome in soybean. Its platform aims to deliver season-long yield protection against high-impact agricultural diseases while preserving beneficial organisms.
Founders & leadership
Robigo was founded in 2021 by Andee Wallace, PhD.
AW
Andee Wallace, PhDinFounder | Chief Executive Officer
Investors · 10
Congruent VenturesSan Francisco · $100K – $5M
Endeavor8San Francisco
First Star VenturesCambridge · $100K – $1M
Good Growth CapitalCharleston
SUPPLY CHANGE CAPITALChicago · $200K – $1M
The E14 FundCambridge · $1M – $5M
Aera VCreportedSingapore · $25K – $5M
Morningside GroupreportedHong Kong
SVG VenturesreportedSilicon Valley
SVG Ventures | THRIVEreportedSilicon Valley · $10K – $100K
Funding
SEC filings, press & company announcements- Undisclosed amountSeedFeb 2023Source ↗
- Undisclosed amountpre-seed fundingNov 2021
First Star Ventures, Morningside Group
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 5
by search overlap
bio8 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Bridgebio7 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Korro Bio7 shared keywordsKorro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.
Ruby7 shared keywordsRuby Bio develops biosynthesis technology and scale-up solutions for specialty chemicals, biofuels, and alternative proteins. The company serves manufacturers and food producers seeking sustainable, bio-derived alternatives to traditional chemical and protein sources.
RoosterBio4 shared keywordsA stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.
Companies competing with Robigo for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Robigo do?
- Robigo develops engineered microbial crop protection products for growers, including a biological solution targeting Sudden Death Syndrome in soybean. Its platform aims to deliver season-long yield protection against high-impact agricultural diseases while preserving beneficial organisms.
- Who founded Robigo?
- Robigo was founded by Andee Wallace, PhD in 2021.
- Who are Robigo's investors?
- Robigo's investors include Congruent Ventures, Endeavor8, First Star Ventures, Good Growth Capital, SUPPLY CHANGE CAPITAL, The E14 Fund, Aera VC, Morningside Group and 2 more.